- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT00067236
Study of Oral PG-116800 Following a Heart Attack
A Multicenter, Randomized, Double-blind, Placebo-controlled Study of Oral PG-116800 Following a Heart Attack
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
Heart attacks cause damage to heart muscle that can weaken the heart and lead to changes in the shape and pumping ability of the heart. These changes can lead to heart failure. An enzyme called metalloproteinase (MMP) plays a role in this damage.
The main purpose of the study is to test whether a possible new drug (called PG-116800) that interferes with the MMP enzyme can prevent some of the damage to heart muscle in patients who have had a heart attack. The study will also supply information regarding possible uses of this compound in cardiovascular disease.
This is a Phase II "proof-of-concept" study; that is, it is a first attempt to treat sick people with the drug to see if it works.
The study is interventional since we will be using a drug to interfere with the heart tissue damage that follows a heart attack.
Studietype
Registrering (Faktiske)
Fase
- Fase 2
Kontakter og plasseringer
Studiesteder
-
-
Alberta
-
Calgary, Alberta, Canada, T2N 4N1
- Foothills Hospital
-
Edmonton, Alberta, Canada, T6G 2B7
- University of Alberta Hospital
-
Edmonton, Alberta, Canada, T6L 5X8
- Grey Nuns Hospital
-
Edmonton, Alberta, Canada, T5G 3C8
- Royal Alexandra Hospital
-
-
British Columbia
-
Campbell River, British Columbia, Canada, V9W 5Y4
- Alder Medical Centre
-
Vancouver, British Columbia, Canada, V5Z 4E3
- Vancouver General Hospital
-
Victoria, British Columbia, Canada, V8R 4R2
- Victoria Heart Institute
-
-
New Brunswick
-
St. John's, New Brunswick, Canada, A1B 3V6
- St. John's HSC
-
-
Nova Scotia
-
Halifax, Nova Scotia, Canada, B3H 3H7
- Queen Elizabeth II HSC
-
-
Ontario
-
Newmarket, Ontario, Canada, L3Y 2R2
- Southlake Regional HC
-
Scarborough, Ontario, Canada, M1S 4V5
- Scarborough Grace Hospital
-
Toronto, Ontario, Canada, M5B 1W8
- St. Michael's Hospital
-
Toronto, Ontario, Canada, M4C 3E7
- Toronto East General
-
-
Quebec
-
Fleurimont, Quebec, Canada, J1H 5N4
- CHUS, Hopital Fleurimont
-
Montreal, Quebec, Canada, H1T 1C8
- Montreal Heart Institute
-
Montreal, Quebec, Canada, H3G 1A4
- Montreal General Hospital
-
Montreal, Quebec, Canada, H3A 1A1
- McGill University Health Centre, Royal Victoria Hospital
-
Montreal, Quebec, Canada, H4J 1C5
- Hopital Sacre-Coeur
-
Ste-Foy, Quebec, Canada, G1V 4G5
- Hôpital Laval
-
-
-
-
Arkansas
-
Little Rock, Arkansas, Forente stater, 72205
- University of Arkansas for Medical Sciences and Central Arkansas Veterans Health Care System
-
-
California
-
Merced, California, Forente stater, 95340
- Mercy Community Medical Center
-
-
Colorado
-
Denver, Colorado, Forente stater, 80210
- Porter Adventist Hospital
-
-
Connecticut
-
Farmington, Connecticut, Forente stater, 06030-2202
- University of Connecticut Health Center
-
-
Florida
-
Atlantis, Florida, Forente stater, 33462
- JFK Medical Center
-
Clearwater, Florida, Forente stater, 33756
- Morton Plant Hospital
-
-
Georgia
-
Atlanta, Georgia, Forente stater, 30309
- Piedmont Hospital
-
-
Michigan
-
Detroit, Michigan, Forente stater, 48202
- Henry Ford Hospital
-
-
Minnesota
-
Minneapolis, Minnesota, Forente stater, 55407-1139
- Abbott-Northwestern Hospital
-
-
Missouri
-
St. Louis, Missouri, Forente stater, 63110
- Barnes Jewish Hospital
-
-
New York
-
Rochester, New York, Forente stater, 14642
- Strong Memorial Hospital
-
-
North Carolina
-
Charlotte, North Carolina, Forente stater, 28204
- Presbyterian Hospital
-
Greensboro, North Carolina, Forente stater, 27401
- Moses Cone Hospital
-
-
Oklahoma
-
Oklahoma City, Oklahoma, Forente stater, 73120
- Oklahoma Heart Hospital
-
-
Pennsylvania
-
Greensburg, Pennsylvania, Forente stater, 15601-2745
- Westmoreland Regional Hospital
-
Hershey, Pennsylvania, Forente stater, 17033-0850
- Hershey Medical Center
-
-
Rhode Island
-
Providence, Rhode Island, Forente stater, 02903
- Rhode Island Hospital
-
-
South Carolina
-
Charleston, South Carolina, Forente stater, 29403
- Medical University of South Carolina
-
-
Tennessee
-
Chattanooga, Tennessee, Forente stater, 37404-1127
- Memorial Hospital
-
-
Texas
-
Houston, Texas, Forente stater, 77030
- Memorial Hermann Hospital
-
-
West Virginia
-
Morgantown, West Virginia, Forente stater, 26506-9157
- West Virginia University Hospital
-
-
-
-
-
Bialystok, Polen
- Klinika Kardiologii, Panstwowy Szpital Kliniczny
-
Bydgoszcz, Polen
- Katedra i Klinika Kardiologii i Chorob Wewnetznych, Akademia Medyczna w Bydgoszczy
-
Katowice, Polen
- 1 Katedra Kardiologii Slaskiej Akademii Medycznej
-
Krakow, Polen
- Klinika Chorob Serca i Naczyn, Krakowski Szpital Specjalistyczny
-
Krakow, Polen
- Oddzial Kardiologii, Wojewodzki Szpital Specjalistyczny
-
Lodz, Polen
- Klinika Kardiologii IMW, Uniwersytet Medyczny w Lodzi
-
Poznan, Polen
- I Klinika Kardilogii Akademii Medycznej w Poznaniu
-
Szczecin, Polen
- Oddzial Internistyczno-Kardiologiczny, Samodzieiny Publiczny Wojewodzki Szpital Zespolony
-
Warszawa, Polen
- I Klinika Choroby Wiencowej, Instytut Kardiologii w Warszawie
-
Warszawa, Polen
- Klinika Choroby Wiencowej, Instytut Kardiologi w Warszawie
-
Warszawa, Polen
- Klinika Kardilogii Inwazyjnej, Centrainy Szpital MSWiA
-
Warszawa, Polen
- Klinika Kardiologii, Szpital Grochowski
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion:
- Be at least 18 years of age but not older than 80 years of age at screening;
- Be diagnosed with a heart attack based on electrocardiogram (ECG) and cardiac enzymes criteria;
- The qualifying heart attack has to be a first heart attack;
- The qualifying heart attack has to result in a left ventricular ejection fraction (a measure of the working efficiency of the heart) between 15% and 40%.
Exclusion:
- Documented previous history of heart attack;
- Any past history of heart failure;
- Hemodynamic instability (no instability of circulatory system);
- History of congenital heart disease and cardiomyopathy (weakened heart muscle) associated with connective tissue disorders;
- Recent history or current moderate-to-severe kidney or liver impairment;
- Significant blood dyscrasias (disorders of the blood cells);
- Females who are currently: pregnant; breast-feeding; or are of childbearing potential.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Dobbelt
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
---|---|
Eksperimentell: PG-116800 tablet
PG-116800 tablet (200 mg) taken twice daily for 90 days
|
200 mg tablet of PG-116800 (given as PG-530742)twice a day for 90 days
|
Placebo komparator: Placebo tablet
Placebo tablet taken twice daily for 90 days
|
placebo tablet, twice a day for 90 days
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Change From Baseline in Left Ventricular End Diastolic Volume Index (LVEDVi in mL/m2) at Day 90 Post Myocardial Infarction (MI)
Tidsramme: 90 days
|
Mean change of left ventricular end diastolic volume index (mL/m2) as evaluated via ventricular end-diastolic volume index augmentation 90 days post Myocardial Infarction (MI)
|
90 days
|
Samarbeidspartnere og etterforskere
Sponsor
Studierekorddatoer
Studer hoveddatoer
Studiestart
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Anslag)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Anslag)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- 2002135
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på Hjerteinfarkt
-
Kitasato UniversityRekrutteringAterosklerose | Akutt koronarsyndrom | Stabil angina | Koronar; Iskemisk | STEMI - ST-segment Elevation Myocardial Infarction | NSTEMI - Non-ST-Segment Elevation Myocardial InfarctionJapan
-
University Hospital, Strasbourg, FranceAvsluttetST Elevatation Myocardial Infarction (STEMI)Frankrike
-
VesalioRekrutteringSegment Elevation Myocardial Infarction (STEMI)Sveits
-
AstraZenecaFullførtHjerteinfarkt | Segment Elevation Myocardial Infarction (STEMI)Australia, Frankrike, Italia, Spania, Storbritannia, Sverige, Tyskland, Ungarn, Danmark, Østerrike, Canada, Nederland, Algerie
-
Capital Medical UniversityFullførtTransradial Approach, Primær PCI, ST-segment Elevation Myocardial InfarctionKina
-
University of Southern CaliforniaAktiv, ikke rekrutterendeNSTEMI - Ikke-ST Segment Elevation MI | Akutt koronarsyndrom (ACS) | STEMI - ST Elevation Myocardial Infarction (MI) | Ustabil angina (UA)Forente stater
-
Izmir Bakircay UniversityFullførtMyocardial Bridge of Coronary ArteryTyrkia
-
ITAB - Institute for Advanced Biomedical TechnologiesAzienda Ospedaliero, Universitaria Ospedali RiunitiFullførtMyocardial Bridge of Coronary ArteryItalia
-
Sichuan Provincial People's HospitalPåmelding etter invitasjonRest Gated Myocardial Perfusion Imaging ved hjertesviktKina
-
Azienda Ospedaliero Universitaria Maggiore della...Università degli Studi del Piemonte Orientale "Amedeo Avogadro"Rekruttering
Kliniske studier på PG-116800 (given as PG-530742)
-
Procter and GambleFullførtArtrose, kneUngarn, Storbritannia